Development of a standardized dissolution test method for inhaled pharmaceutical formulations

International Journal of Pharmaceutics

Volumn 382, Issue 1-2, 2009, Pages 15-22

  Son, Yoen Ju ^a   McConville, Jason T ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Aerosols; Dissolution; Dry powder formulation; Next generation pharmaceutical impactor; Particle size distribution

Indexed keywords

HYDROCORTISONE;

ARTICLE; CHEMICAL COMPOSITION; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG FORMULATION; DRUG SOLUBILITY; DRY POWDER; INHALATION; LUNG FLUID; MOLECULAR DYNAMICS; PARTICLE SIZE; PRIORITY JOURNAL; REPRODUCIBILITY; SIMULATION; STANDARDIZATION;

ADMINISTRATION, INHALATION; AEROSOLS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; EQUIPMENT DESIGN; HYDROCORTISONE; KINETICS; MEMBRANES, ARTIFICIAL; MODELS, CHEMICAL; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 70350211453     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.07.034     Document Type: Article

References (26)

1. Ansoborlo E., Guilmette R.A., Hoover M.D., Chazel V., Houpert P., and Henge-Napoli M.H. Application of in vitro dissolution tests to different uranium compounds and comparison with in vivo data. Radiat. Protect. Dosim. 79 (1998) 33-37
2. Arthanareeswaran G., Thanikaivelan P., Srinivasn K., Mohan D., and Rajendran M. Synthesis, characterization and thermal studies on cellulose acetate membranes with additive. Eur. Polym. J. 40 (2004) 2153-2159
3. Asada M., Takahashi H., Okamoto H., Tanino H., and Danjo K. Theophylline particle design using chitosan by the spray drying. Int. J. Pharm. 270 (2004) 167-174
4. Barichello J.M., Handa H., Kisyuku M., Shibata T., Ishida T., and Kiwada H. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state. J. Control. Release 115 (2006) 94-102
5. Cabrera M.I., Luna J.A., and Grau R.J.A. Modeling of dissolution-diffusion controlled drug release from planar polymeric systems with finite dissolution rate and arbitrary drug loading. J. Membr. Sci. 280 (2006) 693-704
6. Cohen-Atiya M., Vadgama P., and Mandler D. Preparation, characterization and applications of ultrathin cellulose acetate Langmuir-Blodgett films. Soft Matter 3 (2007) 1053-1063
7. Cook R.O., Pannu R.K., and Kellaway I.W. Novel sustained release microspheres for pulmonary drug delivery. J. Control. Release 104 (2005) 79-90
8. Davies N.M., and Feddah M.I.R. A novel method for assessing dissolution of aerosol inhaler products. Int. J. Pharm. 255 (2003) 175-187
9. Grey V.A., Hickey A.J., Balmer P., Davies N.M., Dunbar C., Foster T.S., Olsson B.L., Sakagami M., Shah V.P., Smurthwaite M.J., Veranth J.M., and Zaidi K. The inhalation ad hoc advisory panel for the USP performance tests of inhalation dosage forms. Pharm. Forum 34 (2008) 1068-1074
10. Hayashi T., Yamazaki T., Yamaguchi Y., Sugibayashi K., and Morimoto Y. Release kinetics of indomethacin from pressure sensitive adhesive matrices. J. Control. Release 43 (1997) 213-221
11. Higuchi W.I. Analysis of data on the medicament release from ointments. J. Pharm. Sci. 51 (1962) 802-804
12. Jaspart S., Bertholet P., Piel G., Dogne J.M., Delattre L., and Evrard B. Solid lipid microparticles as a sustained release system for pulmonary drug delivery. Eur. J. Pharm. Biopharm. 65 (2007) 47-56
13. Kesting R.E. Synthetic Polymeric Membranes-A Structural Perspective (1985), Wiley-Interscience, New York
14. Kwon M.J., Bae J.H., Kim J.J., Na K., and Lee E.S. Long acting porous microparticle for pulmonary protein delivery. Int. J. Pharm. 333 (2007) 5-9
15. Learoyd T.P., Burrows J.L., French E., and Seville P.C. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur. J. Pharm. Biopharm. 68 (2008) 224-234
16. Marple V.A., Olson B.A., Santhanakrishnan K., Mitchell J.P., Murray S.C., and Hudson-Curtis B.L. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration. J. Aerosol Med.: Depos. Clear. Effects Lung 16 (2003) 301-324
17. Marple V.A., Roberts D.L., Romay F.J., Miller N.C., Truman K.G., Holroyd M.J., Mitchell J.P., and Hochrainer D. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: Design. J. Aerosol Med.: Depos. Clear. Effects Lung 16 (2003) 283-299
18. Marre S., and Palmeri J. Theoretical study of aerosol filtration by nucleopore filters: the intermediate crossover regime of Brownian diffusion and direct interception. J. Colloid Interface Sci. 237 (2001) 230-238
19. McConville J.T., Patel N., Ditchburn N., Tobyn M.J., Staniforth J.N., and Woodcock P. Use of a novel modified TSI for the evaluation of controlled-release aerosol formulations. I. Drug Develop. Ind. Pharm. 26 (2000) 1191-1198
20. Moss O.R. Simulants of lung interstitial fluid. Health Phys. 36 (1979) 447-448
21. Patton J.S. Mechanisms of macromolecule absorption by the lungs. Adv. Drug Deliv. Rev. 19 (1996) 3-36
22. Pham S., and Wiedmann T.S. Dissolution of aerosol particles of budesonide in Survanta (TM), a model lung surfactant. J. Pharm. Sci. 90 (2001) 98-104
23. Rzepka S., and Neidhart B. Transport processes through track-etch membrane filters in a reagent delivery cell. Fresen. J. Anal. Chem. 366 (2000) 336-340
24. Sdraulig S., Franich R., Tinker R.A., Solomon S., O'Brien R., and Johnston P.N. In vitro dissolution studies of uranium bearing material in simulated lung fluid. J. Env. Radioactivity 99 (2008) 527-538
25. Ungaro F., De Rosa G., Miro A., Quaglia F., and La Rotonda M.I. Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur. J. Pharm. Sci. 28 (2006) 423-432
26. Wiedmann T.S., Bhatia R., and Wattenberg L.W. Drug solubilization in lung surfactant. J. Control. Release 65 (2000) 43-47